Only by Joining Hands Can We Go Far | We Cordially Invite You to Participate in the Distrimap Conference on Innovation and Development of Research Tools and Distribution Channels
Release Date:
2024-11-29 14:45
01 Conference Announcement
by Orange Garden Platform Organized by [organizer name], with co-organization from Dingxiangtong, Aniu You Shuohua, Kasma Platform, and Instrument Learning Network. Distrimap Research Tools Innovation and Development & Distribution Channel Conference Will be December 7 The curtain rises! Here, more than 40 industry leaders will deliver in-depth market analyses based on their respective areas of expertise, comprehensively presenting industry prospects, customer pain points, cutting-edge products, technological trends, service support, and investment attraction policies. Hycells has also been invited to attend this conference.
Amid the ever-changing tides of business, Hycells has steadfastly remained true to his original aspiration. With Innovation as the engine, quality as the cornerstone. , leveraging its deep technological expertise, extensive product portfolio, and robust service ecosystem, has earned widespread market recognition. To better meet market demands and enhance brand influence, We cordially invite distributors from across the country to attend the conference. We sincerely invite discerning individuals to join us in pursuing development and co-creating the future.
Mr. Xie Zhongming, Marketing Director of Hycells The conference will, for the first time, unveil a suite of innovative products and technologies, with live demonstrations highlighting their unique features and real-world applications—providing you with a firsthand competitive edge in the market. A dedicated networking session has also been arranged to facilitate the exchange of insights and best practices. Let us spark innovation through the collision of ideas and build a brighter future through collaboration.
02 Conference Overview
Meeting Name: Distrimap Research Tools Innovation and Development & Distribution Channel Conference
Research Tools Industry Chain Exhibition
Meeting Time: December 7, 2024
Meeting Location: Crowne Plaza Shanghai Pujiang


Related News
HiXpan® Cell Culture Additive: Answers to Key Questions (Part 2)
Hycell’s maximum production capacity per batch is 200–400 units of the 500 mL format, ensuring stable supply and meeting customers’ ongoing production needs.
HiXpan® Cell Culture Additive: Key Questions and Answers (Part 1)
The blood‑derived raw materials used in HiXpan® cell culture additives comply with all regulatory requirements throughout collection, ethical review, informed consent, and commercial authorization, and are supported by a fully traceable supply chain.
This paper focuses on how Hycells transforms biological variability into engineering‑level determinism through a scientifically informed blending strategy and stringent control at the collection end.
(II) Security Assurance Section | Safety First, Defense Prioritized
Compliance‑driven traceability establishes a clear “identity” for the product, but the real test lies in safety. While a multi‑donor pooling strategy ensures batch‑to‑batch consistency, it also inevitably elevates the risk of pathogen introduction. In the face of these associated risks and challenges, Heyousheng has never compromised on its manufacturing standards—relying on more precise design to deliver on its promise of enhanced safety.
This article will examine how Hycells proactively integrates the quality management system into the hospital setting, translating compliance requirements into concrete, actionable practices starting at the sample collection stage, thereby establishing a trust‑based chain that can withstand audit scrutiny.
In selecting hPL raw materials, Heyousheng consistently upholds the principle that “safety is determined at the source.” The samples used in production are rigorously collected in accordance with applicable standards and undergo stringent donor screening, effectively mitigating the risk of disease transmission at the very outset. Moreover, from informed consent forms and ethical approvals to clinical‑grade collection under the GCP framework, Heyousheng has established a fully traceable documentation chain, ensuring that every sample is accounted for and verifiable. In contrast to the industry’s longstanding reliance on the conventional model of using expired blood supplies from blood banks, this approach represents a structural, generational upgrade.